Traing Source
ABIO Split History ยป
Video: Compound Annual Growth Rate (CAGR) Definition

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

Latest Articles

british american tobacco share price history tyson foods stock price history when does ge pay dividends callaway golf stock price history hewlett packard share price today stock symbol for sirius xm radio what is costco stock price history of disney stock splits pacific gas and electric stock price duke energy stock quote today time warner cable stock price history jpmorgan chase & co stock price colgate palmolive stock price today first niagara bank stock price stock price for michael kors green mountain coffee stock symbol chicago bridge and iron share price maxim integrated products stock price stanley black and decker stock quote xm satellite radio stock price fifth third bancorp stock price exxon mobil stock price dividend bny mellon stock price history pitney bowes stock price today stock price of hewlett packard jpmorgan chase bank stock quote pitney bowes stock price today sirius xm radio stock price general electric closing stock price wells fargo stock split history barnes and noble stock price history
Date Open High Low Close Volume
01/12/2018 $1.75 $1.75 $1.60 $1.65 589.30K
01/16/2018 $1.65 $1.70 $1.60 $1.65 486.90K
01/17/2018 $1.65 $1.70 $1.55 $1.60 974.60K
01/18/2018 $1.60 $1.65 $1.55 $1.55 353.60K
01/19/2018 $1.55 $1.65 $1.55 $1.60 316.60K
ARCA biopharma is a biopharmaceutical company principally focused on developing genetically-targeted therapies for cardiovascular diseases. Co.'s key product candidate, Gencaro™ (bucindolol hydrochloride), is a pharmacological beta-blocker and mild vasodilator that Co. is developing for the treatment of patients with atrial fibrillation, and chronic heart failure with reduced left ventricular ejection fraction. Co. also has pharmacogenetic and other patent rights to drug candidates that have potential indications in cardiovascular disease, oncology and other therapeutic areas, in both early and later stages of development.
ABIO historical stock prices picture
ARCA biopharma (ABIO) has the following price history information. Looking back at ABIO historical stock prices for the last five trading days, on January 12, 2018, ABIO opened at $1.75, traded as high as $1.75 and as low as $1.60, and closed at $1.65. Trading volume was a total of 589.30K shares. On January 16, 2018, ABIO opened at $1.65, traded as high as $1.70 and as low as $1.60, and closed at $1.65. Trading volume was a total of 486.90K shares. On January 17, 2018, ABIO opened at $1.65, traded as high as $1.70 and as low as $1.55, and closed at $1.60. Trading volume was a total of 974.60K shares. On January 18, 2018, ABIO opened at $1.60, traded as high as $1.65 and as low as $1.55, and closed at $1.55. Trading volume was a total of 353.60K shares. On January 19, 2018, ABIO opened at $1.55, traded as high as $1.65 and as low as $1.55, and closed at $1.60. Trading volume was a total of 316.60K shares.

ABIO Historical Stock Prices By Date:

ABIO historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into ARCA biopharma shares, starting with a $10,000 purchase of ABIO, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 01/22/2008
End date: 01/19/2018
Start price/share: $1,327.20
End price/share: $1.60
Dividends collected/share: $0.00
Total return: -99.88%
Average Annual Total Return: -48.94%
Starting investment: $10,000.00
Ending investment: $12.05
Years: 10.00
Date Close
ABIO is categorized under the Healthcare sector; below are some other companies in the same sector:

ABLX Historical Stock Prices
ABMD Historical Stock Prices
ABT Historical Stock Prices
ABUS Historical Stock Prices
ACAD Historical Stock Prices
ACER Historical Stock Prices
ACET Historical Stock Prices
ACHC Historical Stock Prices
ACHN Historical Stock Prices
ACHV Historical Stock Prices

ABIO Historical Stock Prices | | Copyright © 2013 - 2018, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following . Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; , and .